CytomX Therapeutics, Inc. earnings per share and revenue

CTMX earnings per share for the last quarter are 0.07 USD whereas the estimation was -0.17 USD which accounts for 140.62% surprise. Company revenue for the same period amounts to 33.43 M USD despite the estimated figure of 17.10 M USD. Estimated earnings per share for the next quarter are -0.20 USD, and revenue is expected to reach 13.53 M USD. Also watch annual changes over time to get a bigger picture of CTMX earnings per share and revenue dynamics.